In an initial public offering (IPO) on Thursday morning, Multi Packaging Solutions International Inc. (NYSE: MPSX) sold 16.5 million shares at an IPO price of $13 a share. The company downsized the offer from a planned 18.8 million shares in an expected price range of $15 to $17 a share. Shares opened at $12.90, but had climbed to around $14.60 in the noon hour, up more than 12% on the day.

Multi Packaging Solutions is a global provider of value-added specialty packaging solutions focused on high complexity products for the consumer, health care and multimedia markets. Joint bookrunners for the offering are Bank of America Merrill Lynch, Barclays and Citigroup. Co-managers include Credit Suisse, Goldman Sachs, UBS Investment Bank, Baird and BMO Capital Markets. The underwriters have a 30-day option to purchase up to 2.48 million additional shares.

The company sold 15.5 million shares in the offering, an increase from the 12.5 million it had originally planned to sell. Selling shareholders sold approximately 1 million shares, well below the 6.25 million shares they originally planned to sell. Two private equity firms, Dearborn Partners and Carlyle Group, chose not to sell at the IPO.

Thursday’s other IPO, Dimension Therapeutics Inc. (NASDAQ: DMTX), priced 5.5 million shares at $13 a share, below the expected range of $14 to $16. The gene therapy platform company is focused on discovering and developing new therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations. Joint bookrunners for the offering are Goldman Sachs and Citigroup. Lead manager is Wells Fargo Securities and co-managers are Canaccord Genuity and Cantor Fitzgerald. The underwriters have a 30-day option to acquire an additional 825,000 shares.

Dimension Therapeutics traded down about 11.5% in the noon hour, at $11.51 in an opening day range of $11.25 to $12.75.

Multi Packaging Solutions traded up about 12.4%, at $14.62 in a first-day range of $12.90 to $14.92.

ALSO READ: A Wall Street Legend Has 7 Top Reasons the Markets Should Go Higher

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.